Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/ Analysts to be held on Tuesday, August 9, 2022 at 10:30 A.M 1ST to discuss the financial and operating performance for Q1 FY 23. Rainbow Children's Medicare Ltd - 543524 - Board Meeting Intimation for To Inter-Alia Consider And Approve The Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30, 2022.
Rainbow Children''s Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors is scheduled to be held on Monday, August 8, 2022 to inter-alia consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the Company for the Quarter ended June 30, 2022. Rainbow Children's Medicare Ltd - 543524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a copy of the Certificate received from KFIN Technologies Limited, the RTA (Registrars & Share Transfer Agent) of the Company viz. Rainbow Children''s Medicare Limited, confirming the compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2022. Rainbow Children's Medicare Ltd - 543524 - Closure of Trading Window
We wish to inform you that as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company shall be closed from July 1, 2022 and would be re-opened after 48 hours from the date of announcement/ declaration of Financial Results for the Quarter ending June 30, 2022. Rainbow Children's Medicare Ltd - 543524 - Resignation Of Group Chief Operating Officer
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, this is to inform you that Dr. Rohit Manipal Bhojaraj, Group Chief Operating Officer, has tendered his resignation owing to personal reasons, the company has accepted his resignation, which will be effective from close of business hours on June 15, 2022. The handing over process is underway and the company has already initiated the process to identify a replacement. In the interim, till a replacement assumes the role, Dr. Ramesh Kancharla, Chairman and Managing Director and Dr. Dinesh Kumar Chirla, Whole Time Director, would be handling the responsibilities of the Group Chief Operating Officer and there would be no disruption in the functioning of the organization. We request you to kindly take the same on record. Rainbow Children's Medicare Ltd - 543524 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2022. Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached herewith Financial Results Webcast Transcript of the Company for Q4 & FY22. Rainbow Children's Medicare Ltd - 543524 - Disclosure Under Regulation 30(5) Of SEBI(LODR)
Pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find attached details of Key Managerial Personnel (KMP) of the Company authorised jointly to determine materiality of an event or information. Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading)Regulations, 2015 as amended, please find enclosed herewith Code of Practices and Procedures for Fair Disclosures of Unpublished Price Sensitive Information(UPSI). Rainbow Childrens Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the recording of results webcast dated May 30, 2022 for Q4 & FY22 with Investors/ Analysts is available on the Company''s website at https://www.rainbowhospitals.in/investor-relations/reports/RCML%20Webcast_30052022.mp4